ADVANCED/METASTATIC CLEAR CELL RENAL CELL CARCINOMA
Clinical trials for ADVANCED/METASTATIC CLEAR CELL RENAL CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ADVANCED/METASTATIC CLEAR CELL RENAL CELL CARCINOMA trials appear
Sign up with your email to follow new studies for ADVANCED/METASTATIC CLEAR CELL RENAL CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New cell therapy targets Hard-to-Treat kidney cancer
Disease control OngoingThis study tests a new cell therapy called AB-2100 for people with advanced or metastatic clear-cell kidney cancer that has come back after other treatments. About 37 to 130 participants will receive the therapy to see if it is safe and shrinks tumors. The goal is to control the …
Matched conditions: ADVANCED/METASTATIC CLEAR CELL RENAL CELL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Arsenal Biosciences, Inc. • Aim: Disease control
Last updated May 26, 2026 10:30 UTC
-
Engineered immune cells take on Hard-to-Treat kidney cancer
Disease control OngoingThis early-phase study tests a new treatment called ALLO-316 for people with advanced or metastatic clear cell renal cell carcinoma who have already tried other therapies. The treatment uses specially designed immune cells (CAR T cells) from a donor, along with chemotherapy to pr…
Matched conditions: ADVANCED/METASTATIC CLEAR CELL RENAL CELL CARCINOMA
Phase: PHASE1 • Sponsor: Allogene Therapeutics • Aim: Disease control
Last updated May 26, 2026 10:27 UTC